BRD2 and breast carcinoma: This study measured serum levels of reproductive hormones, namely, luteinizing hormone (LH), E2, P, testosterone (T), follicle-stimulating hormone (FSH), and prolactin (PRL) in postmenopausal patients with breast cancer.